CPC Cell Processing Center
A CPC facility matters, but it’s only one piece of the puzzle when you’re looking at stem-cell options in Japan. We pull together the cell source, processing controls, public Japanese records, disease-specific evidence, total cost and follow-up into one organized review—so you know what you’re working with before committing time or money.
Just send over the diagnosis summary, any protocol or quote you’ve been given, and whatever recent reports you have on hand. We’ll sort out what’s confirmed, what’s still uncertain, and which questions deserve a written answer.
What a CPC can tell you — and what it cannot.
In Japan, the regulatory route depends on where the cells are processed—notification for certain on-site facilities, permission for certain off-site ones, and accreditation for overseas processors. The status on record should correspond to the facility that’s actually handling your cells.
Facility status
Ask for the facility number and whether the current Japanese record shows notification, permission or overseas accreditation for the actual processing location.
Exact cell product
Confirm tissue source, patient-derived or donor-derived cells, culture or differentiation steps, dose, route and the number of planned administrations.
Release decision
Ask which tests and acceptance criteria apply to the batch, who authorizes release, and what happens if a result is outside the specified range.
Traceability
Collection identity, processing records, storage, transport conditions and chain of custody should remain traceable to the correct cell batch and recipient.
Do not decide from the words “stem cell” alone.
“Stem cell therapy” isn’t one thing. It can mean anything from a simple joint injection to a complex surgical implant. Your thinking sharpens when four details line up.
Diagnosis and stage
Evidence needs to involve the same disease, a comparable stage and a reasonably similar patient group.
Cell product
Cell source, processing method and final product should be comparable to what was actually studied.
Dose and delivery
Intravenous, joint, spinal or surgical delivery are not interchangeable. Dose and repeat schedules also matter.
Outcome and follow-up
Know what was measured, when it was measured and whether the change was meaningful to daily function.
What current evidence actually looks like.
A single percentage can’t capture what “stem-cell success” means, because the cell type, disease, study design and endpoint all vary. Here’s what that actually looks like.
Survival is an important endpoint for some cancers and transplant settings, but it is often not the main effectiveness measure for joint, diabetes, Parkinson’s or early spinal-cord studies. Use the outcome that matches the disease and the study.
Have a protocol, quote or report already?
Send over what you’ve got. When documents come from different clinics or labs, it’s easy to overlook details—we’ll help you spot them.
Could a protocol fit your situation?
A diagnosis name by itself doesn’t tell you whether a protocol fits. Screening can shift the risk picture—or even show that the procedure shouldn’t move forward.
Diagnosis and stage
Diagnostic reports, imaging, pathology where relevant, duration and current functional level.
Previous care
Medication, rehabilitation, surgery, prior procedures and whether the condition is stable or changing.
Baseline health
Infection status, blood counts, coagulation, heart, lungs, liver, kidneys and other relevant conditions.
Medicines and precautions
Anticoagulants, immune-suppressing medicines, allergies and reproductive status when relevant to the protocol.
Procedure exposure
Collection method, dose, route, anesthesia or surgery, repeat dosing and any added medication.
Follow-up plan
Objective reassessment, rehabilitation, complication contact, later testing and handover after returning home.
Budget for the full pathway, not a headline number.
Self-pay asking prices in Japan aren’t standardised—they shift with the cell source, dose, route, number of sessions, and which services are actually included in the quote.
Public asking-price examples reviewed in August 2026; they are not an official tariff, a personal quote or evidence of benefit. A written quote should state screening, collection, processing, release testing, administration, storage, repeat procedures, rehabilitation, follow-up and how complication-related costs are handled.
See the full Japan cost guideSix answers worth getting in writing.
Not every cell product uses the same test panel or release specification. The controls that matter are the ones defined for the exact product, process and intended use—not a generic checklist.
Facility record
Facility number, processing location and current notification, permission or accreditation status.
Cell identity
Tissue source, recipient identity, batch identity and how mix-ups are prevented across processing steps.
Release tests
Applicable identity, viability, contamination or other quality tests and the acceptance criteria used for that product.
Out-of-range handling
Who decides whether a batch can be released and what happens when a specification is not met.
Storage and transport
Time, temperature, container, thawing where relevant and chain-of-custody controls before administration.
Deviation traceability
How processing deviations, complaints, serious events and later investigations can be traced back to the batch record.
One clear record instead of scattered information.
Our support is non-clinical. We organize the information you already have, check public records and sources, prepare practical questions, and coordinate language or travel details if you choose to continue.
Send what you already have
Diagnosis summary, recent reports, protocol name, quote, consent material or other documents available to you.
We organize the facts
Cell source and processing, claimed regulatory status, disease-specific evidence, cost items, follow-up and missing information.
You get a prioritized question list
Questions are grouped by what should be confirmed before payment, travel or any major commitment.
If you decide to continue
We can coordinate document translation, communication preparation and practical travel steps without making the medical decision for you.
Do not let one good answer replace the other three.
Regulatory status
Does the public record match the exact plan, product and processing route being discussed?
Processing quality
Are the source, manufacturing steps, release controls, storage and traceability defined for the exact batch?
Clinical evidence
Does human evidence match the same diagnosis, stage, cell product, dose, route and endpoint?
Practical fit
Do the screening requirements, full cost, rehabilitation and long-term follow-up make sense for your situation?
Go deeper only where it changes your decision.
Stem Cell Treatment Costs in Japan
Public self-pay examples and what a written quote should include.
Is Stem Cell Therapy Safe in Japan?
Risk classes, product approval, precautions and public-record checks.
Japan Registration and Compliance
How to distinguish a filed provision plan from product approval.
Medical Travel Guide for Japan
Records, timing, translation, budget and return-home follow-up.
Knee Osteoarthritis Evidence
Randomized evidence, symptom outcomes and current limits.
Stem-Cell-Derived Islet Research
Human diabetes research and why it cannot be generalized to other products.
Spinal Cord Injury Research
Early human data, recovery measures and long-term safety follow-up.
MSC Research for Chronic Pain
Evidence quality, endpoints and questions that need a specific answer.
CPC and stem-cell decision FAQ.
Short answers to the points most likely to change a decision.
Does CPC status mean a stem-cell intervention is proven effective?
Does using my own cells make the procedure risk-free?
Can I use a published success rate to predict my own result?
What should I look at instead of a general survival rate?
How quickly should improvement happen?
What is enough to start a conversation with you?
Get the details clear before you commit time or money.
Send your diagnosis summary, a protocol name, a quote—whatever records you have. We’ll pull together the key facts, flag the unanswered questions, and lay out practical next steps so everything’s clearer.
We provide information and non-clinical coordination only. We don’t diagnose, we don’t decide whether you’re eligible, and we don’t select a treatment path or promise results. Any personal medical decision needs a licensed professional who has the exact product or protocol and your full medical history.